Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Infections 1Granuloma 1Empyema 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Cone-Beam Computed Tomography × Clear all
NCT01287013 2018-01-05

Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures

National Institutes of Health Clinical Center (CC)

Phase NA Terminated
87 enrolled 10 charts

Empyema, Granuloma, Infections, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡